Research Paper Volume 4, Issue 11 pp 755—767

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

Figure 2. The effect of MIA-690 on the progressive changes of the probe parameters of the 5XFAD transgenic mice in Morris water maze (MWM) experiments. Mice were treated with daily subcutaneous injections of GHRH antagonist MIA-690 at doses of 2, 5, and 10 μg for 6 months. Data are represented as mean ± SEM.